BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 35691421)

  • 1. Identification of amino acid substitutions escaping from a broadly neutralizing monoclonal antibody of feline calicivirus.
    Fujita S; Koba R; Tohya Y
    Virus Res; 2022 Sep; 318():198848. PubMed ID: 35691421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genogrouping of vaccine breakdown strains (VBS) of feline calicivirus in Japan.
    Ohe K; Sakai S; Takahasi T; Sunaga F; Murakami M; Kiuchi A; Fukuyama M; Furuhata K; Hara M; Ishikawa Y; Taneno A
    Vet Res Commun; 2007 May; 31(4):497-507. PubMed ID: 17225086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mapping neutralizing and non-neutralizing epitopes on the capsid protein of feline calicivirus.
    Geissler K; Schneider K; Truyen U
    J Vet Med B Infect Dis Vet Public Health; 2002 Feb; 49(1):55-60. PubMed ID: 11911594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conserved Surface Residues on the Feline Calicivirus Capsid Are Essential for Interaction with Its Receptor Feline Junctional Adhesion Molecule A (fJAM-A).
    Lu Z; Ledgerwood ED; Hinchman MM; Dick R; Parker JSL
    J Virol; 2018 Apr; 92(8):. PubMed ID: 29386293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mapping of antigenic sites involved in neutralization on the capsid protein of feline calicivirus.
    Tohya Y; Yokoyama N; Maeda K; Kawaguchi Y; Mikami T
    J Gen Virol; 1997 Feb; 78 ( Pt 2)():303-5. PubMed ID: 9018050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of an avirulent FCV strain with a broad serum cross-neutralization profile and protection against challenge of a highly virulent vs feline calicivirus.
    Rong S; Lowery D; Floyd-Hawkins K; King V
    Virus Res; 2014 Aug; 188():60-7. PubMed ID: 24685673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Production of a monoclonal antibody reacted broadly with feline calicivirus field isolates.
    Tajima T; Yoshizaki S; Nakata E; Tohya Y; Ishiguro S; Fujikawa Y; Sugii S
    J Vet Med Sci; 1998 Feb; 60(2):155-60. PubMed ID: 9524937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic and phylogenetic analysis of capsid gene of feline calicivirus in Nanjing, China.
    Liang J; Zang M; Zhou Z
    Infect Genet Evol; 2022 Sep; 103():105323. PubMed ID: 35777531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutralizing feature of commercially available feline calicivirus (FCV) vaccine immune sera against FCV field isolates.
    Hohdatsu T; Sato K; Tajima T; Koyama H
    J Vet Med Sci; 1999 Mar; 61(3):299-301. PubMed ID: 10331208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple Correspondence Analysis on Amino Acid Properties within the Variable Region of the Capsid Protein Shows Differences between Classical and Virulent Systemic Feline Calicivirus Strains.
    Brunet S; Sigoillot-Claude C; Pialot D; Poulet H
    Viruses; 2019 Nov; 11(12):. PubMed ID: 31771183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of feline calicivirus (FCV) from vaccinated cats and phylogenetic analysis of its capsid genes.
    Ohe K; Sakai S; Sunaga F; Murakami M; Kiuchi A; Fukuyama M; Furuhata K; Hara M; Soma T; Ishikawa Y; Taneno A
    Vet Res Commun; 2006 Apr; 30(3):293-305. PubMed ID: 16437305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neutralizing epitopes of feline calicivirus.
    Tohya Y; Masuoka K; Takahashi E; Mikami T
    Arch Virol; 1991; 117(3-4):173-81. PubMed ID: 1708228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A dual-strain feline calicivirus vaccine stimulates broader cross-neutralization antibodies than a single-strain vaccine and lessens clinical signs in vaccinated cats when challenged with a homologous feline calicivirus strain associated with virulent systemic disease.
    Huang C; Hess J; Gill M; Hustead D
    J Feline Med Surg; 2010 Feb; 12(2):129-37. PubMed ID: 19836282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A multi-national European cross-sectional study of feline calicivirus epidemiology, diversity and vaccine cross-reactivity.
    Afonso MM; Pinchbeck GL; Smith SL; Daly JM; Gaskell RM; Dawson S; Radford AD
    Vaccine; 2017 May; 35(20):2753-2760. PubMed ID: 28389099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenotypic and genotypic variation of feline calicivirus during persistent infection of cats.
    Kreutz LC; Johnson RP; Seal BS
    Vet Microbiol; 1998 Jan; 59(2-3):229-36. PubMed ID: 9549862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of feline calicivirus and the distribution of serum neutralizing antibody against isolate strains in cats of Hangzhou, China.
    Zheng M; Li Z; Fu X; Lv Q; Yang Y; Shi F
    J Vet Sci; 2021 Sep; 22(5):e73. PubMed ID: 34553518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation and characterization of neutralizing monoclonal antibodies to feline calicivirus.
    Tohya Y; Taniguchi Y; Tsubakimoto M; Takahashi E; Mikami T
    Nihon Juigaku Zasshi; 1990 Apr; 52(2):251-6. PubMed ID: 1693408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quasispecies evolution of a hypervariable region of the feline calicivirus capsid gene in cell culture and in persistently infected cats.
    Radford AD; Turner PC; Bennett M; McArdle F; Dawson S; Glenn MA; Williams RA; Gaskell RM
    J Gen Virol; 1998 Jan; 79 ( Pt 1)():1-10. PubMed ID: 9460915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular characterization and virus neutralization patterns of severe, non-epizootic forms of feline calicivirus infections resembling virulent systemic disease in cats in Switzerland and in Liechtenstein.
    Willi B; Spiri AM; Meli ML; Samman A; Hoffmann K; Sydler T; Cattori V; Graf F; Diserens KA; Padrutt I; Nesina S; Berger A; Ruetten M; Riond B; Hosie MJ; Hofmann-Lehmann R
    Vet Microbiol; 2016 Jan; 182():202-12. PubMed ID: 26711049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of conformational neutralizing epitopes on the capsid protein of canine calicivirus.
    Matsuura Y; Tohya Y; Mochizuki M; Takase K; Sugimura T
    J Gen Virol; 2001 Jul; 82(Pt 7):1695-1702. PubMed ID: 11413381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.